| Authors: |
Kämpf S; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Hematianlarki M; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Altmann L; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Bright JM; Nuvig Therapeutics Inc., Palo Alto, California, USA., Toda AM; Nuvig Therapeutics Inc., Palo Alto, California, USA., Mirzapoor Z; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Zollner V; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Werner A; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Bulang J; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Radovani B; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Wöhner M; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Avery W; Nuvig Therapeutics Inc., Palo Alto, California, USA., Karbarz MJ; Nuvig Therapeutics Inc., Palo Alto, California, USA., Conley PB; Nuvig Therapeutics Inc., Palo Alto, California, USA., Coffey GP; Nuvig Therapeutics Inc., Palo Alto, California, USA., Nimmerjahn F; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany. |
